5WHZ

PGDM1400-10E8v4 CODV Fab


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.549 Å
  • R-Value Free: 0.287 
  • R-Value Work: 0.239 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.

Xu, L.Pegu, A.Rao, E.Doria-Rose, N.Beninga, J.McKee, K.Lord, D.M.Wei, R.R.Deng, G.Louder, M.Schmidt, S.D.Mankoff, Z.Wu, L.Asokan, M.Beil, C.Lange, C.Leuschner, W.D.Kruip, J.Sendak, R.Do Kwon, Y.Zhou, T.Chen, X.Bailer, R.T.Wang, K.Choe, M.Tartaglia, L.J.Barouch, D.H.O'Dell, S.Todd, J.P.Burton, D.R.Roederer, M.Connors, M.Koup, R.A.Kwong, P.D.Yang, Z.Y.Mascola, J.R.Nabel, G.J.

(2017) Science 358: 85-90

  • DOI: 10.1126/science.aan8630

  • PubMed Abstract: 
  • The development of an effective AIDS vaccine has been challenging because of viral genetic diversity and the difficulty of generating broadly neutralizing antibodies (bnAbs). We engineered trispecific antibodies (Abs) that allow a single molecule to ...

    The development of an effective AIDS vaccine has been challenging because of viral genetic diversity and the difficulty of generating broadly neutralizing antibodies (bnAbs). We engineered trispecific antibodies (Abs) that allow a single molecule to interact with three independent HIV-1 envelope determinants: the CD4 binding site, the membrane-proximal external region (MPER), and the V1V2 glycan site. Trispecific Abs exhibited higher potency and breadth than any previously described single bnAb, showed pharmacokinetics similar to those of human bnAbs, and conferred complete immunity against a mixture of simian-human immunodeficiency viruses (SHIVs) in nonhuman primates, in contrast to single bnAbs. Trispecific Abs thus constitute a platform to engage multiple therapeutic targets through a single protein, and they may be applicable for treatment of diverse diseases, including infections, cancer, and autoimmunity.


    Organizational Affiliation

    Sanofi, 640 Memorial Drive, Cambridge, MA 02139, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Anti-HIV CODV-Fab Light chain
L
338N/AMutation(s): 0 
Protein Feature View is not available: No corresponding UniProt sequence found.
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Anti-HIV CODV-Fab Heavy chain
H
396N/AMutation(s): 0 
Protein Feature View is not available: No corresponding UniProt sequence found.
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 3.549 Å
  • R-Value Free: 0.287 
  • R-Value Work: 0.239 
  • Space Group: P 65 2 2
Unit Cell:
Length (Å)Angle (°)
a = 151.226α = 90.00
b = 151.226β = 90.00
c = 200.595γ = 120.00
Software Package:
Software NamePurpose
PHENIXrefinement
XDSdata reduction
PDB_EXTRACTdata extraction
XDSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

  • Deposited Date: 2017-07-18 
  • Released Date: 2017-10-11 
  • Deposition Author(s): Lord, D.M., Wei, R.R.

Revision History 

  • Version 1.0: 2017-10-11
    Type: Initial release
  • Version 1.1: 2017-10-18
    Type: Database references